| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.091 | 0.5 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |